William W. Ericson - 15 Mar 2023 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Role
Director
Signature
/s/ Michele Farmer, Attorney-in-fact
Issuer symbol
PACB
Transactions as of
15 Mar 2023
Net transactions value
-$3,615
Form type
4
Filing time
17 Mar 2023, 17:31:54 UTC
Previous filing
27 May 2022
Next filing
26 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Options Exercise $63,500 +25,000 +1871% $2.54 26,336 15 Mar 2023 Direct
transaction PACB Common Stock Sale $67,115 -7,541 -29% $8.90 18,795 15 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PACB Stock Option (right to buy) Options Exercise $0 -25,000 -100% $0.000000* 0 15 Mar 2023 Common Stock 25,000 $2.54 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold to cover the exercise price of soon-to-expire stock options.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $8.84 to $8.93 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The shares subject to the option are fully vested and exercisable.